|
시장보고서
상품코드
1807707
세포주 개발 시장 : 규모, 점유율, 동향, 산업 분석 보고서 : 제품 및 서비스별, 공급원별, 세포주 유형별, 용도별, 지역별 - 시장 예측(2025-2034년)Cell Line Development Market Size, Share, Trends, & Industry Analysis Report By Product & Service, By Source, By Type of Cell Lines, By Application, and By Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면, 세계 세포주 개발 시장 규모는 2034년까지 154억 3,000만 달러에 달할 것으로 예측됩니다. 이 보고서는 현재 시장 역학에 대한 상세한 통찰력과 미래 시장 성장에 대한 분석을 제공합니다.
세포주 개발은 높은 생산성, 유전적 안정성 및 일관된 치료 효과를 보장하기 위해 바이오 의약품 제조, 백신 개발, 약물 스크리닝을 위한 안정된 세포주 제작 및 선별을 포함합니다. 제약기업과 생명공학 기업들이 바이오 의약품 개발을 가속화하고, 생산 비용을 절감하고, 제품 품질을 향상시키기 위해 첨단 세포주 공학 기술을 채택하는 사례가 증가함에 따라 시장은 계속 확대되고 있습니다.
시장 성장의 원동력은 재조합 단백질 및 세포 기반 백신에 대한 전 세계적인 수요 증가입니다. 종양학, 감염성 질환, 개인 맞춤형 의료 분야의 R&D 비용 증가는 CRISPR 유전자 편집 및 일회용 바이오리액터와 같은 혁신적인 세포주 공학 기술의 채택을 촉진하고 있습니다. 또한, 바이오의약품 제조 인프라에 대한 투자 증가와 전문 CDMO와의 전략적 아웃소싱 파트너십은 세계 치료용 바이오의약품의 대량 생산에 기여하고 있습니다.
세포주 개발 시장 보고서 하이라이트
제품 및 서비스별로는 시약 및 배지 부문이 2024년 가장 큰 시장 점유율을 차지했습니다. 이는 바이오의약품 제조에서 세포의 증식, 안정성, 생산성을 향상시키는 고품질의 화학적으로 정의된 배지에 대한 수요가 증가하고 있기 때문입니다.
공급원별로는 포유류 세포주 부문이 시장을 독점하고 있습니다. 이는 복잡한 치료용 단백질의 생산 효율이 높고, 바이오 의약품 제조에서 더 우수한 효능과 안전성이 보장되기 때문입니다.
세포주 유형별로는 하이브리도마 부문이 가장 빠른 성장이 예상됩니다. 이는 하이브리도마 스크리닝 및 선별 기술의 발전과 함께 종양학, 자가면역학, 감염 치료제의 단일클론항체 생산에 대한 수요 증가에 기인합니다.
용도별로는 재조합 단백질, 바이오시밀러, 백신의 대규모 생산에 안정적인 세포주 채택이 증가함에 따라 바이오 생산 부문이 2024년 가장 높은 점유율을 차지할 것으로 예측됩니다.
북미는 선진적인 제조 인프라와 주요 생명공학 기업 및 CDMO의 존재에 힘입어 2024년 세포주 개발 세계 시장을 독식할 것으로 예측됩니다.
아시아태평양은 바이오의약품 산업의 급격한 성장과 중국, 인도 등 비용 효율성이 높은 시장으로의 세포주 개발 서비스 아웃소싱 증가로 인해 꾸준한 성장세를 보이고 있습니다.
세계 주요 시장 기업으로는 Lonza Group AG, WuXi Biologics, Thermo Fisher Scientific Inc. Biologics,Cellistic,Berkeley Lights,Advanced Instruments,Danaher Corporation,Creative Biolabs 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 세포주 개발 시장 인사이트
- 시장 현황
- 세포주 개발 시장 역학
- 성장 촉진요인과 기회
- 전 세계 암증례 증가
- 세계의 연구개발비 확대
- 성장 억제요인과 과제
- 고비용이며, 시간이 소요되는 개발 프로세스
- 성장 촉진요인과 기회
- PESTEL 분석
- 세포주 개발 시장 동향
- 밸류체인 분석
제5장 세계의 세포주 개발 시장 : 제품 및 서비스별
- 주요 조사 결과
- 서론
- 시약 및 배지
- 장비
- 액세서리 및 소모품
- 독성 시험
제6장 세계의 세포주 개발 시장 : 공급원별
- 주요 조사 결과
- 서론
- 포유류 세포주
- 비포유류 세포주
제7장 세계의 세포주 개발 시장 : 세포주 유형별
- 주요 조사 결과
- 서론
- 재조합 세포주
- 잡종 세포
- 상용 세포주
- 1차 세포 주식
제8장 세계의 세포주 개발 시장 : 용도별
- 주요 조사 결과
- 서론
- 바이오프로덕션
- Drug Discovery
- 독성 시험
- 조직공학
- 기타
제9장 세계의 세포주 개발 시장 : 지역별
- 주요 조사 결과
- 서론
- 세포주 개발 시장 평가 : 지역별, 2020-2034년
- 북미
- 북미 : 제품 및 서비스별, 2020-2034년
- 북미 : 공급원별, 2020-2034년
- 북미 : 세포주 유형별, 2020년-2034년
- 북미 : 용도별, 2020-2034년
- 미국
- 캐나다
- 유럽
- 유럽 : 제품 및 서비스별, 2020-2034년
- 유럽 : 공급원별, 2020-2034년
- 유럽 : 세포주 유형별, 2020-2034년
- 유럽 : 용도별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 제품 및 서비스별, 2020년-2034년
- 아시아태평양 : 공급원별, 2020-2034년
- 아시아태평양 : 세포주 유형별, 2020년-2034년
- 아시아태평양 : 용도별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 제품 및 서비스별, 2020-2034년
- 중동 및 아프리카 : 공급원별, 2020-2034년
- 중동 및 아프리카 : 세포주 유형별, 2020-2034년
- 중동 및 아프리카 : 용도별, 2020-2034년
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 제품 및 서비스별, 2020-2034년
- 라틴아메리카 : 공급원별, 2020-2034년
- 라틴아메리카 : 세포주 유형별, 2020년-2034년
- 라틴아메리카 : 용도별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제10장 경쟁 구도
- 사업 확대 및 인수 분석
- 사업 확대
- 인수
- 제휴, 협업, 협정 및 공개
제11장 기업 개요
- Advanced Instruments
- Berkeley Lights
- Cellistic
- Charles River Laboratories
- Creative Biolabs
- Cytovance Biologics
- Danaher Corporation
- Lonza Group AG
- Merck KGaA
- Sartorius AG
- Thermo Fisher Scientific Inc.
- WuXi Biologics
The cell line development market size is expected to reach USD 15.43 billion by 2034, according to a new study by Polaris Market Research. The report "Cell Line Development Market Share, Size, Trends, Industry Analysis Report: By Product & Service, By Source, By Type of Cell Lines, By Application, and By Region; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Cell line development includes generation and selection of stable cell lines for biologics production, vaccine development and for drug screening purposes that ensure high productivity, genetic stability, and consistent therapeutic output. The market continues to expand as pharmaceutical and biotechnology companies increasingly adopt advanced cell line engineering technologies to accelerate biologics development, reduce production costs, and improve product quality.
The market growth is fueled by the rising global demand for recombinant proteins and cell-based vaccines. Increasing R&D expenditure in oncology, infectious diseases, and personalized medicine is boosting the adoption of innovative cell line engineering techniques, including CRISPR gene editing and single-use bioreactors. Additionally, growing investments in biopharmaceutical manufacturing infrastructure and strategic outsourcing partnerships with specialized CDMOs are helping large-scale production of therapeutic biologics worldwide.
Cell Line Development Market Report Highlights
Based on product and service, the reagents & media segment accounted for the largest market share in 2024, due to the rising demand for high-quality, chemically defined media that enhance cell growth, stability, and productivity in biologics manufacturing.
Based on source, the mammalian cell line segment dominated the market, driven by its high efficiency in producing complex therapeutic proteins that ensures better efficacy and safety in biologics manufacturing.
Based on type of cell lines, the hybridomas segment is expected to witness the fastest growth, fueled by increasing demand for monoclonal antibody production in oncology, autoimmune, and infectious disease therapeutics, along with advancements in hybridoma screening and selection techniques.
Based on application, the bioproduction segment held the dominant share in 2024, due to the rising adoption of stable cell lines for large-scale manufacturing of recombinant proteins, biosimilars, and vaccines.
North America dominated the global cell line development market in 2024, fueled by advanced manufacturing infrastructure, and the presence of leading biotechnology firms and CDMOs.
Asia Pacific witnessed a steady growth, driven by rapid expansion of the regional biopharmaceutical industry and increasing outsourcing of cell line development services to cost-efficient markets such as China and India.
A few global key market players include Lonza Group AG, WuXi Biologics, Thermo Fisher Scientific Inc., Sartorius AG, Charles River Laboratories, Merck KGaA, Cytovance Biologics, Cellistic, Berkeley Lights, Advanced Instruments, Danaher Corporation, and Creative Biolabs.
Polaris Market Research has segmented the market report on the basis of product & service, source, type of cell lines, application, and region:
By Product & Service Outlook (Revenue, USD Billion, 2020-2034)
Reagent and Media
Equipment
Automated Systems
Centrifuges
Bioreactors
Storage Equipment
Others
Accessories and Consumables
Services
By Source Outlook (Revenue, USD Billion, 2020-2034)
Mammalian Cell Line
Non-Mammalian Cell Line
Insects
Amphibians
By Type of Cell Lines (Revenue, USD Billion, 2020-2034)
Recombinant Cell Lines
Hybridomas
Continuous Cell Lines
Primary Cell Lines
By Application (Revenue, USD Billion, 2020-2034)
Bioproduction
Drug Discovery
Toxicity Testing
Tissue Engineering
Others
By Regional Outlook (Revenue, USD Billion, 2020-2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Cell Line Development Market Insights
- 4.1. Cell Line Development Market - Market Snapshot
- 4.2. Cell Line Development Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Cases of Cancer Worldwide
- 4.2.1.2. Rising Global R&D Expenditure
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High cost and time-intensive development process
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Cell Line Development Market Trends
- 4.6. Value Chain Analysis
5. Global Cell Line Development Market, by Product & Service
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 5.3. Reagent and Media
- 5.3.1. Global Cell Line Development Market, by Reagent and Media, by Region, 2020-2034 (USD Billion)
- 5.4. Equipment
- 5.4.1. Global Cell Line Development Market, by Equipment, by Region, 2020-2034 (USD Billion)
- 5.5. Accessories and Consumables
- 5.5.1. Global Cell Line Development Market, by Accessories and Consumables, by Region, 2020-2034 (USD Billion)
- 5.6. Toxicity Testing
- 5.6.1.1. Global Cell Line Development Market, by Toxicity Testing, by Region, 2020-2034 (USD Billion)
6. Global Cell Line Development Market, by Source
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 6.3. Mammalian Cell Line
- 6.3.1. Global Cell Line Development Market, by Mammalian Cell Line, by Region, 2020-2034 (USD Billion)
- 6.4. Non-Mammalian Cell Line
- 6.4.1. Global Cell Line Development Market, by Non-Mammalian Cell Line, by Region, 2020-2034 (USD Billion)
7. Global Cell Line Development Market, by Type of Cell Lines
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 7.3. Recombinant Cell Lines
- 7.3.1. Global Cell Line Development Market, by Recombinant Cell Lines, by Region, 2020-2034 (USD Billion)
- 7.4. Hybridomas
- 7.4.1. Global Cell Line Development Market, by Hybridomas, by Region, 2020-2034 (USD Billion)
- 7.5. Continuous Cell Lines
- 7.5.1. Global Cell Line Development Market, by Continuous Cell Lines, by Region, 2020-2034 (USD Billion)
- 7.6. Primary Cell Lines
- 7.6.1. Global Cell Line Development Market, by Primary Cell Lines, by Region, 2020-2034 (USD Billion)
8. Global Cell Line Development Market, by Application
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 8.3. Bioproduction
- 8.3.1. Global Cell Line Development Market, by Bioproduction, by Region, 2020-2034 (USD Billion)
- 8.4. Drug Discovery
- 8.4.1. Global Cell Line Development Market, by Drug Discovery, by Region, 2020-2034 (USD Billion)
- 8.5. Toxicity Testing
- 8.5.1. Global Cell Line Development Market, by Toxicity Testing, by Region, 2020-2034 (USD Billion)
- 8.6. Tissue Engineering
- 8.6.1. Global Cell Line Development Market, by Tissue Engineering, by Region, 2020-2034 (USD Billion)
- 8.7. Others
- 8.7.1. Global Cell Line Development Market, by Others, by Region, 2020-2034 (USD Billion)
9. Global Cell Line Development Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Cell Line Development Market Assessment, By Geography, 2020-2034 (USD Billion)
- 9.3. Cell Line Development Market - North America
- 9.3.1. North America: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.3.2. North America: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.3.3. North America: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.3.4. North America: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.3.5. Cell Line Development Market - U.S.
- 9.3.5.1. U.S.: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.3.5.2. U.S.: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.3.5.3. U.S.: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.3.5.4. U.S.: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.3.6. Cell Line Development Market - Canada
- 9.3.6.1. Canada: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.3.6.2. Canada: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.3.6.3. Canada: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.3.6.4. Canada: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.4. Cell Line Development Market - Europe
- 9.4.1. Europe: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.4.2. Europe: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.4.3. Europe: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.4.4. Europe: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.4.5. Cell Line Development Market - UK
- 9.4.5.1. UK: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.4.5.2. UK: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.4.5.3. UK: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.4.5.4. UK: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.4.6. Cell Line Development Market - France
- 9.4.6.1. France: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.4.6.2. France: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.4.6.3. France: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.4.6.4. France: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.4.7. Cell Line Development Market - Germany
- 9.4.7.1. Germany: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.4.7.2. Germany: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.4.7.3. Germany: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.4.7.4. Germany: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.4.8. Cell Line Development Market - Italy
- 9.4.8.1. Italy: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.4.8.2. Italy: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.4.8.3. Italy: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.4.8.4. Italy: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.4.9. Cell Line Development Market - Spain
- 9.4.9.1. Spain: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.4.9.2. Spain: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.4.9.3. Spain: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.4.9.4. Spain: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.4.10. Cell Line Development Market - Netherlands
- 9.4.10.1. Netherlands: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.4.10.2. Netherlands: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.4.10.3. Netherlands: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.4.10.4. Netherlands: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.4.11. Cell Line Development Market - Russia
- 9.4.11.1. Russia: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.4.11.2. Russia: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.4.11.3. Russia: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.4.11.4. Russia: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.4.12. Cell Line Development Market - Rest of Europe
- 9.4.12.1. Rest of Europe: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.4.12.2. Rest of Europe: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.4.12.3. Rest of Europe: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.4.12.4. Rest of Europe: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.5. Cell Line Development Market - Asia Pacific
- 9.5.1. Asia Pacific: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.5.5. Cell Line Development Market - China
- 9.5.5.1. China: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.5.5.2. China: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.5.5.3. China: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.5.5.4. China: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.5.6. Cell Line Development Market - India
- 9.5.6.1. India: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.5.6.2. India: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.5.6.3. India: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.5.6.4. India: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.5.7. Cell Line Development Market - Malaysia
- 9.5.7.1. Malaysia: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.5.7.2. Malaysia: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.5.7.3. Malaysia: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.5.7.4. Malaysia: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.5.8. Cell Line Development Market - Japan
- 9.5.8.1. Japan: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.5.8.2. Japan: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.5.8.3. Japan: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.5.8.4. Japan: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.5.9. Cell Line Development Market - Indonesia
- 9.5.9.1. Indonesia: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.5.9.2. Indonesia: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.5.9.3. Indonesia: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.5.9.4. Indonesia: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.5.10. Cell Line Development Market - South Korea
- 9.5.10.1. South Korea: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.5.10.2. South Korea: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.5.10.3. South Korea: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.5.10.4. South Korea: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.5.11. Cell Line Development Market - Australia
- 9.5.11.1. Australia: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.5.11.2. Australia: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.5.11.3. Australia: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.5.11.4. Australia: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.5.12. Cell Line Development Market - Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.5.12.2. Rest of Asia Pacific: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.5.12.3. Rest of Asia Pacific: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.5.12.4. Rest of Asia Pacific: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.6. Cell Line Development Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.6.5. Cell Line Development Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.6.5.2. Saudi Arabia: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.6.5.3. Saudi Arabia: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.6.5.4. Saudi Arabia: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.6.6. Cell Line Development Market - UAE
- 9.6.6.1. UAE: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.6.6.2. UAE: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.6.6.3. UAE: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.6.6.4. UAE: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.6.7. Cell Line Development Market - Israel
- 9.6.7.1. Israel: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.6.7.2. Israel: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.6.7.3. Israel: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.6.7.4. Israel: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.6.8. Cell Line Development Market - South Africa
- 9.6.8.1. South Africa: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.6.8.2. South Africa: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.6.8.3. South Africa: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.6.8.4. South Africa: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.6.9. Cell Line Development Market - Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.6.9.2. Rest of Middle East & Africa: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.6.9.3. Rest of Middle East & Africa: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.6.9.4. Rest of Middle East & Africa: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.7. Cell Line Development Market - Latin America
- 9.7.1. Latin America: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.7.5. Cell Line Development Market - Mexico
- 9.7.5.1. Mexico: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.7.5.2. Mexico: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.7.5.3. Mexico: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.7.5.4. Mexico: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.7.6. Cell Line Development Market - Brazil
- 9.7.6.1. Brazil: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.7.6.2. Brazil: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.7.6.3. Brazil: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.7.6.4. Brazil: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.7.7. Cell Line Development Market - Argentina
- 9.7.7.1. Argentina: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.7.7.2. Argentina: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.7.7.3. Argentina: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.7.7.4. Argentina: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
- 9.7.8. Cell Line Development Market - Rest of Latin America
- 9.7.8.1. Rest of Latin America: Cell Line Development Market, by Product & Service, 2020-2034 (USD Billion)
- 9.7.8.2. Rest of Latin America: Cell Line Development Market, by Source, 2020-2034 (USD Billion)
- 9.7.8.3. Rest of Latin America: Cell Line Development Market, by Type of Cell Lines, 2020-2034 (USD Billion)
- 9.7.8.4. Rest of Latin America: Cell Line Development Market, by Application, 2020-2034 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Advanced Instruments
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product & Service Benchmarking
- 11.1.4. Recent Development
- 11.2. Berkeley Lights
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product & Service Benchmarking
- 11.2.4. Recent Development
- 11.3. Cellistic
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product & Service Benchmarking
- 11.3.4. Recent Development
- 11.4. Charles River Laboratories
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product & Service Benchmarking
- 11.4.4. Recent Development
- 11.5. Creative Biolabs
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product & Service Benchmarking
- 11.5.4. Recent Development
- 11.6. Cytovance Biologics
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product & Service Benchmarking
- 11.6.4. Recent Development
- 11.7. Danaher Corporation
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product & Service Benchmarking
- 11.7.4. Recent Development
- 11.8. Lonza Group AG
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product & Service Benchmarking
- 11.8.4. Recent Development
- 11.9. Merck KGaA
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product & Service Benchmarking
- 11.9.4. Recent Development
- 11.10. Sartorius AG
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product & Service Benchmarking
- 11.10.4. Recent Development
- 11.11. Thermo Fisher Scientific Inc.
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product & Service Benchmarking
- 11.11.4. Recent Development
- 11.12. WuXi Biologics
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product & Service Benchmarking
- 11.12.4. Recent Development
